Literature DB >> 9207257

Helicobacter pylori infection and chronic gastric acid hyposecretion.

E M El-Omar1, K Oien, A El-Nujumi, D Gillen, A Wirz, S Dahill, C Williams, J E Ardill, K E McColl.   

Abstract

BACKGROUND & AIMS: We have identified a subgroup of Helicobacter pylori-infected subjects with low or absent gastric acid output. The aim of this study was to document the morphological and functional abnormalities in these subjects and to assess the effect of eradicating the infection.
METHODS: The 16 hypochlorhydric subjects (6 men) had a mean age of 55 years (range, 36-79 years). They underwent a 14C-urea breath test, H. pylori serology, fasting gastrin, gastric autoantibodies, gastroscopy with antral and body biopsies, and measurement of peak acid output to pentagastrin (PAO(PG)). Their histology was compared with that of age- and sex-matched duodenal ulcer and nonulcer dyspepsia patients (16 each). H. pylori infection was eradicated in the hypochlorhydric subjects, and the investigations were repeated 6 months later.
RESULTS: Compared with controls, the hypochlorhydric subjects had less dense H. pylori colonization, body-predominant colonization and gastritis, and increased prevalence of body atrophy and intestinal metaplasia. Median PAO(PG) before eradication in the hypochlorhydric subjects was 1.1 mmol/h and increased to 12.6 mmol/h after eradication (P < 0.001), with no significant change in body atrophy or intestinal metaplasia.
CONCLUSIONS: In some subjects, chronic H. pylori infection produces a body-predominant gastritis and profound suppression of gastric acid secretion that is partially reversible with eradication therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9207257     DOI: 10.1016/s0016-5085(97)70075-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  144 in total

Review 1.  Topical review. Gastrin and gastric epithelial physiology.

Authors:  G J Dockray
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

Review 2.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 3.  Update in internal medicine.

Authors:  F López-Jiménez; M Brito; Y W Aude; P Scheinberg; M Kaplan; D A Dixon; N Schneiderman; J F Trejo; L H López-Salazar; E J Ramírez-Barba; R Kalil; C Ortiz; J Goyos; A Buenaño; S Kottiech; G A Lamas
Journal:  Arch Med Res       Date:  2000 Jul-Aug       Impact factor: 2.235

4.  Mechanisms involved in Helicobacter pylori induced duodenal ulcer disease:an overview.

Authors:  Lars Olbe; Lars Fandriks; Annika Hamlet; Ann-Mari Svennerholm; Ann-Catrin Thoreson
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

5.  Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.

Authors:  M F Dixon
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

6.  The importance of interleukin 1beta in Helicobacter pylori associated disease.

Authors:  E M El-Omar
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

7.  Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 8.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

9.  Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils.

Authors:  M Takashima; T Furuta; H Hanai; H Sugimura; E Kaneko
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

10.  Relationship of sliding hiatus hernia to gastroesophageal reflux disease: a possible role for Helicobacter pylori infection?

Authors:  Gianpiero Manes; Oreste Pieramico; Generoso Uomo; Sandro Mosca; Claudio de Nucci; Antonio Balzano
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.